Murine Fibrinogen

Synonyms: 小鼠纤维蛋白原
Murine Fibrinogen 是一种来自小鼠血浆的天然纤维蛋白原,也是一种脑血管通透性增强剂,可激活基质金属蛋白酶-9 (MMP-9)、下调血管内皮钙粘蛋白 (VE-cadherin) 的表达、上调质膜囊泡相关蛋白-1 (PV-1) 的表达,并可增加软脑膜静脉大分子渗漏,进而破坏脑血管微血管完整性,因此可用于脑血管功能障碍的相关研究。
产品编号: MS-V33862 CAS No.: 9001-32-5
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
3-5 天
5mg
询价
询价
10mg
询价
询价

产品描述

Murine Fibrinogen 是一种来自小鼠血浆的天然纤维蛋白原,也是一种脑血管通透性增强剂,可激活基质金属蛋白酶-9 (MMP-9)、下调血管内皮钙粘蛋白 (VE-cadherin) 的表达、上调质膜囊泡相关蛋白-1 (PV-1) 的表达,并可增加软脑膜静脉大分子渗漏,进而破坏脑血管微血管完整性,因此可用于脑血管功能障碍的相关研究。

生物实验数据

生物活性 Murine Fibrinogen is a natural fibrinogen derived from mouse plasma and a cerebrovascular permeability enhancer that activates matrix metalloproteinase-9 (MMP-9), downregulates the expression of vascular endothelial cadherin (VE-cadherin), upregulates the expression of plasmalemma vesicle-associated protein-1 (PV-1), and increases macromolecular leakage from pial veins, thereby disrupting cerebrovascular microvascular integrity, and can therefore be used in research related to cerebrovascular dysfunction.
IC50 & Target

MMP-9

 

体内研究
(In Vivo)

Murine fibrinogen (按每 100 g 体重给予 20 mg;颈动脉输注;流速 20 mL/min;持续 10 分钟) 可在小鼠中诱导显著的软脑膜静脉大分子渗漏、ICAM-1 和 PV-1 上调、VE-钙粘蛋白下调以及 MMP 活化,而在 MMP9-/- 小鼠中上述效应减弱,提示 MMP-9 介导该试剂的部分脑血管功能障碍作用。

Animal Model: C57BL/6J (12-week-old male, 26-30 g, wild-type); MMP9-/- (FVB.Cg-Mmp9tm1Tvu/J, 12-week-old male, 26-30 g, MMP-9 gene knockout); FVB/NJ (12-week-old male, 26-30 g, wild-type)
Dosage: 20 mg per 100 g of body weight (resulting in a blood concentration of 4 mg/mL)
Administration: carotid artery infusion; 20 mL/min; 10 minutes
Result: Induced significantly greater pial venular macromolecular leakage (fluorescence intensity of 155 FIU) than PBS infusion in wild-type C57BL/6J mice.
Increased endothelial ICAM-1 expression to 50 FIU (vs 22 FIU with PBS) in wild-type C57BL/6J mice.
Reduced VE-cadherin expression to 22 FIU (vs 43 FIU with PBS) in wild-type C57BL/6J mice.
Increased MMP activity to 71 FIU in wild-type C57BL/6J mice.
Increased PV-1 expression to 170 FIU (vs 50 FIU with PBS) in wild-type C57BL/6J mice.
Induced further increased pial venular leakage (fluorescence intensity of 182 FIU) when combined with topical histamine in wild-type C57BL/6J mice.
Induced significantly greater pial venular macromolecular leakage (fluorescence intensity of 137 FIU) than PBS infusion in MMP9-/- mice, but less leakage than in wild-type mice.
Increased endothelial ICAM-1 expression to 39 FIU (vs 24 FIU with PBS) in MMP9-/- mice.
Reduced VE-cadherin expression to 28 FIU (vs 78 FIU with PBS) in MMP9-/- mice, with higher VE-cadherin levels than in Fg-treated wild-type mice.
Increased MMP activity to 46 FIU in MMP9-/- mice, with lower activity than in Fg-treated wild-type mice.
Increased PV-1 expression to 75 FIU (vs 50 FIU with PBS) in MMP9-/- mice, with lower expression than in Fg-treated wild-type mice.
Induced further increased pial venular leakage (fluorescence intensity of 152 FIU) when combined with topical histamine in MMP9-/- mice, but less leakage than in histamine-exposed, Fg-treated wild-type mice.
Induced pial venular macromolecular leakage (fluorescence intensity of 152 FIU) comparable to that in Fg-treated wild-type mice in FVB/NJ mice, with significantly greater leakage than PBS infusion.
Induced further increased pial venular leakage (fluorescence intensity of 178 FIU) when combined with topical histamine in FVB/NJ mice, comparable to that in histamine-exposed, Fg-treated wild-type mice.
Showed no degradation post-infusion.
性状 固体
颜色 White to off-white

化学信息

CAS No. 9001-32-5
别名 小鼠纤维蛋白原

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础